| pubmed-article:6427003 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6427003 | lifeskim:mentions | umls-concept:C0330390 | lld:lifeskim |
| pubmed-article:6427003 | lifeskim:mentions | umls-concept:C0007589 | lld:lifeskim |
| pubmed-article:6427003 | lifeskim:mentions | umls-concept:C1955875 | lld:lifeskim |
| pubmed-article:6427003 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:6427003 | lifeskim:mentions | umls-concept:C1152102 | lld:lifeskim |
| pubmed-article:6427003 | lifeskim:mentions | umls-concept:C1511938 | lld:lifeskim |
| pubmed-article:6427003 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6427003 | pubmed:dateCreated | 1984-7-9 | lld:pubmed |
| pubmed-article:6427003 | pubmed:abstractText | Exposure of F9 cells to all-trans-retinoic acid over a period of 6 days resulted in 4-fold induction of cell surface N-acetylglucosaminide beta (1----4)galactosyltransferase (GT) activity. The retinoic acid-induced GT activity was further enhanced by treatment of the cells with 8-bromo cyclic AMP. The ability of retinoic acid alone, or retinoic acid in combination with 8-bromo cyclic AMP, to induce GT activity was inhibited by both actinomycin D and cycloheximide. These findings indicate that the induction of galactosyltransferase activity noted with differentiation of F9 cells involves de novo synthesis of new enzyme protein. | lld:pubmed |
| pubmed-article:6427003 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6427003 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6427003 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6427003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6427003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6427003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6427003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6427003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6427003 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6427003 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6427003 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:6427003 | pubmed:issn | 0014-5793 | lld:pubmed |
| pubmed-article:6427003 | pubmed:author | pubmed-author:AndersonW BWB | lld:pubmed |
| pubmed-article:6427003 | pubmed:author | pubmed-author:NakhasiH LHL | lld:pubmed |
| pubmed-article:6427003 | pubmed:author | pubmed-author:NagarajanLL | lld:pubmed |
| pubmed-article:6427003 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6427003 | pubmed:day | 26 | lld:pubmed |
| pubmed-article:6427003 | pubmed:volume | 168 | lld:pubmed |
| pubmed-article:6427003 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6427003 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6427003 | pubmed:pagination | 222-6 | lld:pubmed |
| pubmed-article:6427003 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:meshHeading | pubmed-meshheading:6427003-... | lld:pubmed |
| pubmed-article:6427003 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6427003 | pubmed:articleTitle | Increase in cell-surface N-acetylglucosaminide beta (1----4)galactosyltransferase activity with retinoic acid-induced differentiation of F9 embryonal carcinoma cells. | lld:pubmed |
| pubmed-article:6427003 | pubmed:publicationType | Journal Article | lld:pubmed |
